Mengqi Fang

Broadly resistant HIV-1 against CD4-binding site neutralizing antibodies

Linqi Zhang, T. Zhou, Xuanling Shi, 2019, PLoS pathogens.

A pathogen-like antigen-based vaccine confers immune protection against SARS-CoV-2 in non-human primates

H. Deng, H. Hang, P. Zhu, 2021, Cell Reports Medicine.

Preclinical characterization of amubarvimab and romlusevimab, a pair of non-competing neutralizing monoclonal antibody cocktail, against SARS-CoV-2

Xinquan Wang, M. Frieman, J. Ge, 2022, Frontiers in Immunology.

Comparison between SARS-CoV and SARS-CoV 2

Mengqi Fang, 2021, E3S Web of Conferences.

Study on flexible surface dielectric barrier discharge plasma film for in situ inactivation of bacteria and viruses

Yuntao Guo, Mengqi Fang, Haiyun Luo, 2022, Applied Physics Letters.

Potent and protective IGHV3-53/3-66 public antibodies and their shared escape mutant on the spike of SARS-CoV-2

J. Chan, Zhiwei Chen, K. Yuen, 2021, Nature Communications.

A Potent and Protective Human Neutralizing Antibody Against SARS-CoV-2 Variants

J. Chu, Linqi Zhang, Xinquan Wang, 2021, Frontiers in Immunology.